In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy.“This presentation really supported the notion that earlier and continuous treatment yielded better out…
In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses research on managing coexisting geographic atrophy and neovascular age-related macular degeneration in the same eye.“Historically, we haven’t had much real-world data loo…
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches.One year later, much speculation remains regarding the impact this decision will ultimate…
Roughly one-third of U.S. adults — or more than 82 million people — cut back on basic needs such as food, utilities or transportation to pay for health care in the past year, according to new Gallup surveys.One survey of nearly 20,000 U.S. adults condu…
The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release from Johnson & Johnson.A previous analysis of the lens found that 97% of patients reported “no very bothersome visual disturbance…
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of the FDA’s approval of ENCELTO™ (taroretcel-lwey), the…